关注
Kuan-Wei Huang
标题
引用次数
引用次数
年份
Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer
KW Huang, FF Hsu, JT Qiu, GJ Chern, YA Lee, CC Chang, YT Huang, ...
Science advances 6 (3), eaax5032, 2020
1862020
Galactose derivative-modified nanoparticles for efficient siRNA delivery to hepatocellular carcinoma
KW Huang, YT Lai, GJ Chern, SF Huang, CL Tsai, YC Sung, CC Chiang, ...
Biomacromolecules 19 (6), 2330-2339, 2018
672018
A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment
JS Song, CC Chang, CH Wu, TK Dinh, JJ Jan, KW Huang, MC Chou, ...
Proceedings of the National Academy of Sciences 118 (13), e2015433118, 2021
532021
A multifunctional nanocarrier for efficient TRAIL‐based gene therapy against hepatocellular carcinoma with desmoplasia in mice
CH Liu, GJ Chern, FF Hsu, KW Huang, YC Sung, HC Huang, JT Qiu, ...
Hepatology 67 (3), 899-913, 2018
432018
Membrane Protein Modification Modulates Big and Small Extracellular Vesicle Biodistribution and Tumorigenic Potential in Breast Cancers In Vivo
BJA Magoling, YJ Chen, AYT Wu, WWT Wong, STY Chuo, HC Huang, ...
bioRxiv, 2022
182022
Delivery of sorafenib by myofibroblast-targeted nanoparticles for the treatment of renal fibrosis
HT Cheng, HC Huang, TY Lee, YH Liao, YH Sheng, PR Jin, KW Huang, ...
Journal of Controlled Release 346, 169-179, 2022
162022
Long noncoding RNA Smyca coactivates TGF-β/Smad and Myc pathways to drive tumor progression
HY Chen, SJ Chan, X Liu, AC Wei, RI Jian, KW Huang, YD Lang, JH Shih, ...
Journal of hematology & oncology 15 (1), 1-24, 2022
142022
系统目前无法执行此操作,请稍后再试。
文章 1–7